Cyberkinetics Provides Update on Ongoing Clinical Trials of BrainGate Neural Interface System; Report Includes Initial Results From Use of BrainGate by a Person with ALS

Posted byclientekdevPosted instem cell research

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060823005359&newsLang=en

August 23, 2006 (businesswire.com) – Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; "Cyberkinetics") announced that preliminary results from the pilot trials of Cyberkinetics’ BrainGate Neural Interface System (BrainGate) were presented at the Neural Interfaces Workshop in Bethesda, Maryland, sponsored by the National Institute of Neurological Disorders and Stroke …